Rutgers University Study of the Genetics of Breast Cancer.
NCT ID: NCT06773897
Last Updated: 2025-10-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
25000 participants
OBSERVATIONAL
2024-04-15
2027-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Identification of Novel Genetic Factors That Contribute to Risk for Breast Cancer
NCT00276120
Factors Associated With Breast Cancer Risks and Outcomes
NCT07294703
Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast Cancer
NCT01386411
Combined Breast Cancer Risk Study
NCT03067389
Responses to Genetic Risk Modifier Testing Among Women With BRCA1/2 Mutations
NCT03396341
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breast Cancer Cases
Study participants who have been diagnosed with any form of breast cancer, either currently or in the past.
Saliva sample
Saliva sample is sent via prepaid US Mail for DNA extraction
Health Surveys
Health surveys are filled out online in the study portal.
Breast Cancer Controls
Study participants who have never had a diagnosis of breast cancer.
Saliva sample
Saliva sample is sent via prepaid US Mail for DNA extraction
Health Surveys
Health surveys are filled out online in the study portal.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Saliva sample
Saliva sample is sent via prepaid US Mail for DNA extraction
Health Surveys
Health surveys are filled out online in the study portal.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* currently living in the United States
* able to understand and follow written instructions in English
* have access to the internet and a computer, laptop, tablet or smart phone
* willing to provide written informed consent for participation
* willing to provide DNA via a saliva sample using a collection kit mailed to the study participant's home
* willing to complete a survey with questions about health related to the study of breast cancer.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Regeneron Pharmaceuticals
INDUSTRY
Rutgers, The State University of New Jersey
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tara Matise, Ph.D.
Distinguished Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tara Matise, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Rutgers, The State University of New Jersey
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rutgers University
Piscataway, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
Study website with detailed information about the study.
Study portal for participant enrollment and study engagement.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro2023001275
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.